Matches in Nanopublications for { ?s ?p "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1246174.RAQtp6b3cjz4MRyb7EJw2PnpU5RaWBrCQc_SEqvtOJGAE130_assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246174.RAQtp6b3cjz4MRyb7EJw2PnpU5RaWBrCQc_SEqvtOJGAE130_provenance.
- NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246175.RAA2k1FmNV-WnSPUDPnCe-_cOOKIamO68LvAus77T3_Vk130_provenance.
- NP1246176.RAqQ9LWHq2_Pez-WwrMMpTZICBTNFRo9d-TS9QbjbNrGE130_assertion description "[Therapeutically, KRAS mutation testing has maximum utility in stratifying metastatic colorectal carcinoma and lung cancer patients for treatment with targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246176.RAqQ9LWHq2_Pez-WwrMMpTZICBTNFRo9d-TS9QbjbNrGE130_provenance.